Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuto Nishio

Showing results (1-10 of 423) with videos related to

Pageof 43
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Resistance to target-based therapy and its circumvention]Kazuto Nishio
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 17, 2022
[Genomic Analysis-Based Treatment for Cancer of Unknown Primary]Kazuto Nishio
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2015
[Kinase inhibitors and their resistance]Yosuke Togashi, Kazuto Nishio
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 25, 2012
[Biomarker research for a clinical setting]Hideharu Kimura, Kazuto Nishio
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Progress of molecular targeted therapies]Hidetoshi Hayashi, Kazuto Nishio
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 23, 2009
[Molecular diagnostic methods designed for clinical approach to cancer of unknown origin]Yoshihiko Fujita, Kazuto Nishio
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 26, 2017
[Clinical Application of NGS-Based Clinical Sequencing]Kazuto Nishio, Kazuko Sakai
Respirology (Carlton, Vic.)|October 21, 2006
Clinical aspects of epidermal growth factor receptor inhibitors: benefit and riskTefurumi Kato, Kazuto Nishio
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[HER2 (human epidermal growth factor receptor type 2), EGFR (epidermal growth factor receptor)]Tokuzo Arao, Kazuto Nishio
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 19, 2019
[Current Status and Future Direction of Cancer Genomic Medicine]Kazuto Nishio, Kazuko Sakai
Pageof 43

Showing results (1-10 of 423) with videos related to

Sort By:
Pageof 43
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Resistance to target-based therapy and its circumvention]Kazuto Nishio
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 17, 2022
[Genomic Analysis-Based Treatment for Cancer of Unknown Primary]Kazuto Nishio
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2015
[Kinase inhibitors and their resistance]Yosuke Togashi, Kazuto Nishio
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 25, 2012
[Biomarker research for a clinical setting]Hideharu Kimura, Kazuto Nishio
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Progress of molecular targeted therapies]Hidetoshi Hayashi, Kazuto Nishio
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 23, 2009
[Molecular diagnostic methods designed for clinical approach to cancer of unknown origin]Yoshihiko Fujita, Kazuto Nishio
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 26, 2017
[Clinical Application of NGS-Based Clinical Sequencing]Kazuto Nishio, Kazuko Sakai
Respirology (Carlton, Vic.)|October 21, 2006
Clinical aspects of epidermal growth factor receptor inhibitors: benefit and riskTefurumi Kato, Kazuto Nishio
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[HER2 (human epidermal growth factor receptor type 2), EGFR (epidermal growth factor receptor)]Tokuzo Arao, Kazuto Nishio
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 19, 2019
[Current Status and Future Direction of Cancer Genomic Medicine]Kazuto Nishio, Kazuko Sakai
Pageof 43